New drug aims to reduce blood removal in polycythemia vera patients
Disease control
Ongoing
This study tests a new drug called SLN124 in adults with polycythemia vera, a condition where the body makes too many red blood cells. The goal is to see if SLN124 is safe and can reduce the need for phlebotomies (removing blood). The trial has two parts: first, an open-label pha…
Phase: PHASE1, PHASE2 • Sponsor: Silence Therapeutics plc • Aim: Disease control
Last updated May 17, 2026 11:36 UTC